X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023-08-15 | ALT | Drutz David | Dir | P - Purchase | $2.88 | +300 | 29,785 | +1% | +$863 | ||||||
2022-08-12 | ALT | Gill John | Dir | S - Sale | $15.00 | -2,714 | 2,771 | -49% | -$40,710 | ||||||
2023-03-23 | ALT | Drutz David | Dir | P - Purchase | $4.27 | +9,000 | 29,484 | +44% | +$38,430 | ||||||
2023-03-24 | ALT | Eisenstadt Richard I | CFO | P - Purchase | $4.31 | +10,000 | 22,010 | +83% | +$43,140 | ||||||
2023-03-23 | ALT | Harris Matthew Scott | Chief Medical Officer | P - Purchase | $4.22 | +10,000 | 33,311 | +43% | +$42,200 | ||||||
| D | 2022-12-22 | ALT | Pisano Wayne | Dir | S - Sale+OE | $15.01 | -20,000 | 8,498 | -70% | -$300,268 | |||||
2022-08-31 | ALT | Garg Vipin K | Pres, CEO | S - Sale | $20.02 | -20,000 | 236,797 | -8% | -$400,322 | ||||||
2022-08-12 | ALT | Garg Vipin K | Pres, CEO | S - Sale | $15.06 | -15,000 | 259,804 | -5% | -$225,890 | ||||||
| DM | 2022-07-01 | ALT | Roberts M Scot | Chief Scientific Officer | S - Sale+OE | $12.00 | -37,164 | 8,320 | -82% | -$445,968 | |||||
| D | 2022-06-29 | ALT | Roberts M Scot | Chief Scientific Officer | S - Sale+OE | $12.00 | -5,462 | 17,715 | -24% | -$65,546 | |||||
| D | 2022-06-27 | ALT | Roberts M Scot | Chief Scientific Officer | S - Sale+OE | $12.00 | -37,352 | 17,715 | -68% | -$448,254 | |||||
| D | 2022-06-27 | ALT | Jorkasky Diane | Dir | S - Sale+OE | $11.75 | -17,610 | 0 | -100% | -$206,944 | |||||
2022-06-15 | ALT | Drutz David | Dir | P - Purchase | $8.00 | +1,000 | 20,345 | +5% | +$8,000 | ||||||
2022-05-24 | ALT | Drutz David | Dir | P - Purchase | $4.50 | +1,200 | 19,345 | +7% | +$5,400 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |